Of Mice and Men: Bridging the Translational Disconnect in CNS Drug Discovery

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.11, 2009-11, pp. : 915-926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Translational medicine: the discovery of bridging biomarkers using pharmacogenomics

By Mendrick Donna L

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 943-947

Future Medicine

Access to resources Recommend Favorite

Chemogenomics: Bridging a Drug Discovery Gap

Current Medicinal Chemistry, Vol. 9, Iss. 23, 2002-12 ,pp. : 2077-2084

Bentham Science Publishers

Access to resources Recommend Favorite

An overview of CNS drug discovery at Eli Lilly and Company

By Paul S.M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 254-254

Elsevier

Access to resources Recommend Favorite

Modeling of PET data in CNS drug discovery and development

By Varnäs Katarina

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. : 267-279

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 2, 2011-06 ,pp. : 102-122

Bentham Science Publishers

Access to resources Recommend Favorite